Bristol Myers Squibb Reports Positive Phase 3 Resu...
Category : Clinical Trial Update 15 January 2026Bristol Myers Squibb has reported positive topline results from SCOUT-HCM, a Phase 3 trial evaluatin...
Bristol Myers Squibb has reported positive topline results from SCOUT-HCM, a Phase 3 trial evaluatin...
Hyundai Bioscience has announced a major clinical milestone for Xafty™, its broad-spectrum ant...
Armata Pharmaceuticals has received a positive End-of-Phase 2 (EOP2) written response from the US FD...
Johnson & Johnson will present 11 new scientific abstracts across depression, schizophrenia, and...
Thryv Therapeutics has initiated Wave II, a pivotal Phase 2/3 clinical study evaluating THRV-1268, i...